S. Litvak

2.3k total citations
71 papers, 1.8k citations indexed

About

S. Litvak is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, S. Litvak has authored 71 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 26 papers in Infectious Diseases and 26 papers in Virology. Recurrent topics in S. Litvak's work include HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (26 papers) and RNA and protein synthesis mechanisms (15 papers). S. Litvak is often cited by papers focused on HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (26 papers) and RNA and protein synthesis mechanisms (15 papers). S. Litvak collaborates with scholars based in France, Russia and Chile. S. Litvak's co-authors include Laura Tarrago‐Litvak, Alberto Dí­az Araya, Michel Castroviejo, F. Chapeville, J L Darlix, Marie‐Line Andréola, G. Keith, Caroline Gabus, Anne‐Catherine Prats and Dominique Bégu and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

S. Litvak

70 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Litvak France 23 1.4k 411 403 350 126 71 1.8k
M.P. Egloff France 8 797 0.6× 106 0.3× 234 0.6× 313 0.9× 29 0.2× 10 1.4k
Richard H. Smith United States 21 328 0.2× 68 0.2× 206 0.5× 241 0.7× 39 0.3× 37 1.1k
Peter M. Pryciak United States 24 2.0k 1.4× 351 0.9× 276 0.7× 266 0.8× 41 0.3× 35 2.3k
Ahmad Khorchid Canada 16 809 0.6× 49 0.1× 501 1.2× 311 0.9× 107 0.8× 18 1.1k
Harry O. Voorma Netherlands 30 1.9k 1.4× 172 0.4× 38 0.1× 217 0.6× 212 1.7× 91 2.4k
Christian H. Gross United States 20 1.4k 1.0× 146 0.4× 60 0.1× 126 0.4× 92 0.7× 27 1.8k
E. M. Martin Tanzania 22 597 0.4× 179 0.4× 32 0.1× 209 0.6× 86 0.7× 44 1.1k
Jean Lucas‐Lenard United States 22 1.2k 0.9× 127 0.3× 36 0.1× 153 0.4× 134 1.1× 41 1.8k
Sukyeong Lee United States 21 1.6k 1.2× 80 0.2× 66 0.2× 221 0.6× 126 1.0× 42 2.1k
Michel Castroviejo France 22 819 0.6× 562 1.4× 40 0.1× 80 0.2× 78 0.6× 59 1.3k

Countries citing papers authored by S. Litvak

Since Specialization
Citations

This map shows the geographic impact of S. Litvak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Litvak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Litvak more than expected).

Fields of papers citing papers by S. Litvak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Litvak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Litvak. The network helps show where S. Litvak may publish in the future.

Co-authorship network of co-authors of S. Litvak

This figure shows the co-authorship network connecting the top 25 collaborators of S. Litvak. A scholar is included among the top collaborators of S. Litvak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Litvak. S. Litvak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desfarges, Sébastien, Joseph San Filippo, Marjorie Fournier, et al.. (2006). Chromosomal integration of LTR-flanked DNA in yeast expressing HIV-1 integrase: down regulation by RAD51. Nucleic Acids Research. 34(21). 6215–6224. 15 indexed citations
2.
Zakharova, Olga D., Svetlana V. Baranova, V. A. Ryabinin, et al.. (2005). Interaction of HIV-1 Reverse Transcriptase with New Minor Groove Binders and Their Conjugates with Oligonucleotides. Molecular Biology. 39(3). 421–429. 3 indexed citations
3.
Andréola, Marie‐Line, Vaea Richard de Soultrait, Marjorie Fournier, et al.. (2002). HIV-1 integrase and RNase H activities as therapeutic targets. Expert Opinion on Therapeutic Targets. 6(4). 433–446. 17 indexed citations
4.
Parissi, Vincent, Anne Caumont, Vaea Richard de Soultrait, et al.. (2000). Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae. Journal of Molecular Biology. 295(4). 755–765. 17 indexed citations
5.
Reinbolt, Joseph, Michel Castroviejo, Bernard Ehresmann, et al.. (1999). Cross-linking localization of a HIV-1 reverse transcriptase peptide involved in the binding of primer tRNALys3. Journal of Molecular Biology. 285(4). 1339–1346. 22 indexed citations
6.
Zakharova, Olga D., Enzo Sottofattori, Д. В. Пышный, et al.. (1999). Interaction of Oligonucleotides Conjugated to Substituted Chromones and Coumarins with HIV-1 Reverse Transcriptase. Antisense and Nucleic Acid Drug Development. 9(5). 473–480. 13 indexed citations
7.
Ventura, Maria Teresa, et al.. (1999). Effect of nucleoside analogs and non-nucleoside inhibitors of HIV-1 reverse transcriptase on cell-free virions. Archives of Virology. 144(3). 513–523. 13 indexed citations
8.
Boulmé, Florence, et al.. (1998). Initiation of in vitro reverse transcription from tRNALys3 on HIV‐1 or HIV‐2 RNAs by both type 1 and 2 reverse transcriptases. FEBS Letters. 430(3). 165–170. 9 indexed citations
9.
Boulmé, Florence, et al.. (1997). Specific inhibition of in vitro reverse transcription using antisense oligonucleotides targeted to the TAR regions of HIV-1 and HIV-2. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1351(3). 249–255. 7 indexed citations
10.
Boiziau, Claudine, et al.. (1996). Antisense Oligonucleotides Inhibit In Vitro cDNA Synthesis by HIV-1 Reverse Transcriptase. Antisense and Nucleic Acid Drug Development. 6(2). 103–109. 9 indexed citations
11.
Zanlungo, Silvana, et al.. (1995). The cox1 Initiation Codon Is Created by RNA Editing in Potato Mitochondria. PLANT PHYSIOLOGY. 108(3). 1327–1328. 35 indexed citations
12.
13.
Andréola, Marie‐Line, et al.. (1993). The ribonuclease H activity of HIV-1 reverse transcriptase: Further biochemical characterization and search of inhibitors. Biochimie. 75(1-2). 127–134. 11 indexed citations
14.
Andréola, Marie‐Line, et al.. (1993). Affinity labeling and functional analysis of the primer binding domain of HIV-1 reverse transcriptase. Biochemistry. 32(14). 3629–3637. 11 indexed citations
15.
Hernould, Michel, A. Mouras, S. Litvak, & Alejandro Araya. (1992). RNA editing of the mitochondrialatp9transcript from tobacco. Nucleic Acids Research. 20(7). 1809–1809. 8 indexed citations
16.
Bordier, Bruno B., C. Hélène, P J Barr, S. Litvak, & Leila Sarih‐Cottin. (1992). In vitroeffect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription. Nucleic Acids Research. 20(22). 5999–6006. 37 indexed citations
17.
Tarrago‐Litvak, Laura, et al.. (1990). What embryo DNA polymerase a reverse transcribes natural and synthetic RNA templates. Biochemical characterization and comparison with animal DNA polymerase γ and retroviral reverse transcriptase. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1048(2-3). 139–148. 10 indexed citations
18.
Aoyama, Hiroshi & S. Litvak. (1986). RNA-dependent activity for wheat germ DNA polymerase a. Americanae (AECID Library). 29(2). 267–278. 1 indexed citations
19.
Tarrago‐Litvak, Laura, et al.. (1976). Interactions of plant viral RNAs and tRNA nucleotidyl transferase.. Library Stack (Library Stack). 127A(1). 39–46.
20.
Litvak, S., et al.. (1970). TYMV RNA As a substrate of the tRNA nucleotidyltransferase. FEBS Letters. 11(5). 316–319. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.P. Egloff Breakdown of academic impact, for papers by Richard H. Smith Breakdown of academic impact, for papers by Peter M. Pryciak Breakdown of academic impact, for papers by Ahmad Khorchid Breakdown of academic impact, for papers by Harry O. Voorma Breakdown of academic impact, for papers by Christian H. Gross Breakdown of academic impact, for papers by E. M. Martin Breakdown of academic impact, for papers by Jean Lucas‐Lenard Breakdown of academic impact, for papers by Sukyeong Lee Breakdown of academic impact, for papers by Michel Castroviejo
Rankless by CCL
2026